Adverum Biotechnlgs (ADVM) |
|
12.51 -2.39 (-16.04%)
|
08-13 16:00 |
|
Open: |
12.85 |
Pre. Close: |
14.9 |
|
High:
|
13.12 |
Low:
|
11.75 |
|
Volume:
|
10,900,832 |
Market Cap:
|
1,009M |
|
|
|
|
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
13.148 - 13.227 |
13.227 - 13.286 |
|
Low:
|
11.577 - 11.673 |
11.673 - 11.744 |
|
Close:
|
12.377 - 12.527 |
12.527 - 12.638 |
|
Technical analysis |
as of: 2020-08-13 4:31:17 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 20.54  One year: 24.75 |
| Support: |
Support1: 11.75 Support2: 9.78 |
| Resistance: |
Resistance1: 17.58 Resistance2: 21.19 |
| Pivot: |
16.96 |
| Moving Average: |
MA(5): 16.03 MA(20): 17.08
MA(100): 17.42 MA(250): 12.92 |
| MACD: |
MACD(12,26): -1.12 Signal(9): -0.82 |
| Stochastic oscillator: |
%K(14,3): 12.36 %D(3): 32.82 |
| RSI: |
RSI(14): 28.11 |
| 52-week: |
High: 26.98 Low: 4.96 Change(%): -6.6 |
| Average Vol(K): |
3-Month: 128104 10-Days: 202578 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ADVM has closed below the lower band by 22.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 2.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
80 |
| Shares Float (M) |
51 |
|
% Held by Insiders
|
3.34 |
|
% Held by Institutions
|
80.01 |
|
Shares Short (K)
|
10,930 |
|
Shares Short P. Month (K)
|
11,840 |
Stock Financials |
|
EPS
|
-1.090 |
|
EPS Est This Year
|
-1.260 |
|
EPS Est Next Year
|
-1.310 |
|
Book Value (p.s.)
|
3.810 |
|
Profit Margin
|
|
|
Operating Margin
|
-30651.60 |
|
Return on Assets (ttm)
|
-16.8 |
|
Return on Equity (ttm)
|
-29.6 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
-0.500 |
|
Sales Per Share
|
0.003 |
|
EBITDA (p.s.)
|
-0.933 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-50 |
|
Levered Free Cash Flow (M)
|
-50 |
Stock Valuations |
|
PE Ratio
|
-11.48 |
|
PEG Ratio
|
|
|
Price to Book value
|
3.28 |
|
Price to Sales
|
4018.21 |
|
Price to Cash Flow
|
-20.27 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
